Application Sponsors
NDA 020569 | BAUSCH AND LOMB | |
Marketing Status
Application Products
001 | IMPLANT;IMPLANTATION | 4.5MG | 0 | VITRASERT | GANCICLOVIR |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 1996-03-04 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1997-10-17 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 1997-11-26 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 1999-05-14 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 1999-08-04 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 6 | AP | 2000-04-18 | |
Submissions Property Types
ORIG | 1 | Null | 39 |
SUPPL | 2 | Null | 14 |
SUPPL | 3 | Null | 14 |
SUPPL | 4 | Null | 14 |
SUPPL | 5 | Null | 14 |
SUPPL | 6 | Null | 14 |
CDER Filings
BAUSCH AND LOMB
cder:Array
(
[0] => Array
(
[ApplNo] => 20569
[companyName] => BAUSCH AND LOMB
[docInserts] => ["",""]
[products] => [{"drugName":"VITRASERT","activeIngredients":"GANCICLOVIR","strength":"4.5MG","dosageForm":"IMPLANT;IMPLANTATION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"VITRASERT","submission":"GANCICLOVIR","actionType":"4.5MG","submissionClassification":"IMPLANT;IMPLANTATION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)